Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • Cover Letter

  • Title Page
  • Journal Submission Checlist
  • Anonymized Manuscript
  • IEC Certificate
  • Contributor and Copyright Form
  • Conflict of Interest Form

Author Guidelines

Presubmission Instructions

Please go through the Journal Submission Checklist. The checklist can be copied to a Word document, filled out, and submitted along with the manuscript.

Please attach a Cover Letter and Title Page.

Title Page: The title page should include the article title, author name (s), and permanent affiliation (s), and the name, current address, email address, and telephone number of the person to whom page proofs should be sent. It should also mention the Institution Ethics Committee number (attach the original IEC certificate with the manuscript), word count of the article, the number of tables, and the number of figures. The title page should also mention the funding sources. All acknowledgements, declarations of use of AI and chatbots should be made here. Please review the plagiarism and use of AI and Chatbot Policy.  

Please go through the Author's Guidelines.

Please also read the detailed copyright and licence policy.

Please Attach an Author Contributors and CopyrightForm

Please also attach the Conflict of Interest Form for Authors

Articles should be submitted after careful review of the guidelines. It is mandatory to adopt standardized protocols while reporting different types of studies. Standard formats are provided for the convenience of authors. 

Checklists to follow while submitting articles

Cross-Sectional Studies STROBE Checklist 

Cohort Studies STROBE Checklist

Case-control Studies STROBE Checklist

Qualitative Studies SRQR Checklist, COREQ Checklist

Case Report CARE Checklist

Randomized Control Trials CONSORT Checklist

Systematic Reviews PRISMA Checklist

Meta-analysis PRISMA Checklist

For all systematic reviews and meta-analyses (SRMA), protocols must be registered with an international registry, such as the International Prospective Register of Systematic Reviews (PROSPERO), or with a specific registry, such as INPLASY or OSF. Major sites like PROSPERO are backlogged, prompting the use of alternatives such as INPLASY and OSF for timely registration. 

All clinical trials submitted must be registered with the Clinical Trials Registry- India. (CTRI)

Authors need to register with the journal before submitting, or if they are already registered, they can log in and begin the five-step process.

Revised Manuscripts

  • For significant revisions, the authors must provide a letter addressing each reviewer's comments separately and in point form, first recording the reviewer's comment and then following it with the author's response.
  • The author must track all changes made in the revised manuscript.
  • The new drafts should be submitted at this website, under the control panel area for the original submission, using the "Upload Author Version" option under the "Review" tab.

Proofs

The Editors reserve the right to correct errors in grammar, spelling, or punctuation, to clarify obscurities and remove redundancies, to improve infelicities of style, to enhance or change the way the paper is organized, and to ensure that the paper (text and graphics) conforms to the Journal's requirements. No significant changes will be made without consulting the author.

Research Report

KJP will consider studies based on the following-

  • Studies should be well-justified, well-planned, appropriately designed, and ethically approved
  • Studies should follow the COPE guidelines on Good Publication Practice
  • Studies from Kerala meeting the above criteria will receive precedence

The manuscript -

  • Should not exceed 5000 words (excluding references and abstract).
  • The manuscript should include a structured abstract, within 250 words, under the following headings: Background (the rationale for the study); Methods (how the study was done); Results (major findings); Conclusions (a discussion of the results). This structured abstract provides a clear overview of the study, helping readers quickly understand its key points.
  • Should be divided into sections with the following headings: Introduction, Material and Methods, Results, and Discussion.
  • In the Methods section, ethical safeguards must be specified. However, the name of the IEC and the number may be mentioned in the Title Page, to ensure that the manuscript remains anonymized. The section must also provide details of informed consent from human subjects and how it was obtained (written or oral).
  • When data are summarized in the Results section, it is crucial to specify the statistical analysis used. 

Case Series

This section will be for a “collection of subjects with common characteristics used to describe some clinical, pathophysiological, or operational aspects of a disease, treatment, exposure, or diagnostic procedure.”

Case series, unlike case reports, is an abstraction of a series of cases collected over a period of time, which lead to hypotheses regarding new diagnoses, interventions, or side effects, which could be tested further with methodological rigor.

Case series can be synthesized narratively or quantitatively. Patient consent is mandatory while reporting. If quantitative analysis is done, an IEC waiver or clearance ust be taken.

Case Report

  • Should not exceed 1500 words (excluding the abstract and references)
  • Should not use more than 10 references
  • Should have an unstructured abstract within 150 words
  • Should be divided to Introduction, Case report, and Discussion
  • Patient consent is mandatory in case reports

Review Article

  • Should not exceed 5000 words (excluding abstract and references)
  • Should have an unstructured abstract within 200 words

Viewpoint

Experience-based views and opinions on important, debatable or controversial issues that affect the practice of Psychiatry and mental health can be submitted to this section.

  • The author should have sufficient, credible experience on the subject.
  • Should not exceed 3000 words.
  • Need no abstract

New in Psychiatry

Review articles that describe and critically evaluate any new treatment modality that would be of relevance to Psychiatrists practicing in Kerala can be submitted to this section.

  • Should not exceed 3000 words (excluding abstract and references)
  • Should have an unstructured abstract within 200 words

Local Innovation

Detailed descriptions and methodology of any innovative approaches to psychiatric treatment, community interventions, service delivery, etc. implemented and found practical, acceptable and successful (even without any associated objective data) in Kerala settings can be submitted to this section.

  • Should not exceed 2000 words (excluding the references)
  • Should have an unstructured abstract within 200 words

Psychiatry in Kerala

This section will accept articles which examine and review the details of practice of any aspect of Psychiatry in Kerala, suggest steps for improvements in the scenario, etc.

  • Should not exceed 3000 words (excluding the references)
  • Should have an unstructured abstract within 200 words

Rating Scale

Malayalam translations of valid rating scales available in English or other languages can be submitted to this section.

  • Authors should include the details of validation process they have used while translating the scale.
  • Include a copy of the original rating scale in English along with the submission. (The original version will not be published in KJP.)
  • The permission of the original authors is mandatory if the original scale is copyrighted.

Letter to the Editor

  • Need no abstract
  • Should not exceed a word count of 500 (excluding the references)
  • Should not use more than five references.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.